Genetically Modified Foods in the International Arena: Trade Conflicts, Labeling Controversy, and the Importance of Informed Consumer Choice by Deminina, Ilona M.
Brigham Young University International Law & Management
Review
Volume 2 | Issue 2 Article 5
5-26-2006
Genetically Modified Foods in the International
Arena: Trade Conflicts, Labeling Controversy, and
the Importance of Informed Consumer Choice
Ilona M. Deminina
Follow this and additional works at: https://digitalcommons.law.byu.edu/ilmr
Part of the Food Science Commons, and the International Trade Law Commons
This Comment is brought to you for free and open access by BYU Law Digital Commons. It has been accepted for inclusion in Brigham Young
University International Law & Management Review by an authorized editor of BYU Law Digital Commons. For more information, please contact
hunterlawlibrary@byu.edu.
Recommended Citation
Ilona M. Deminina, Genetically Modified Foods in the International Arena: Trade Conflicts, Labeling Controversy, and the Importance of
Informed Consumer Choice, 2 BYU Int'l L. & Mgmt. R. 311 (2006).
Available at: https://digitalcommons.law.byu.edu/ilmr/vol2/iss2/5
 311 
GENETICALLY MODIFIED FOODS IN THE 
INTERNATIONAL ARENA: 
TRADE CONFLICTS, LABELING CONTROVERSY, AND 
THE IMPORTANCE 
OF INFORMED CONSUMER CHOICE 
 
Ilona M. Demenina* 
 
 
I. INTRODUCTION 
 
Do we really know what is in the food we eat? Most of us do 
not know that the majority of foods found in grocery stores in the 
United States contain Genetically Modified (GM) ingredients.1 
Recent studies show that “[a]bout two-thirds of consumers do not 
know supermarkets already offer GE2 food, and according to 
surveys in 2001 and 2003 by the Pew Initiative on Food and 
Biotechnology—an independent biotechnology group—only one in 
five people thinks he or she has eaten a genetically modified 
product.”3 Many U.S. consumers who are aware of GM foods are 
concerned with the possible impacts on human health and the 
environment.4 
The concerns are not unique to U.S. consumers—the public 
worldwide shares them.5 A recent British survey shows that the 
public’s concern about GM foods is rapidly increasing.6 Most 
 
 
* J.D., St. Thomas University (2006); Editor-in-Chief, St. Thomas Law Review; 
B.A. Political Science, University of Alaska-Anchorage (2002). 
1 Elizabeth Suh, GE Foods Still Lacking Consumer Awareness, WASH. TIMES, 
Sept. 2, 2004, http://washingtontimes.com/upi-breaking/20040819-023903-2211r.htm.  
2 The terms GE (Genetically Engineered) and GM (Genetically Modified) will 
be used interchangeably throughout the article. 
3 Suh, supra note 1.  
4 Id.   
5 See Kathleen Hart, An Introduction to Genetically Modified Foods, 10 RICH. 
J.L. & TECH. 6 (2004) (In April of 2004, about one-fifth of the Austrian adults urged 
the government to ban GM foods. “Fifteen grocery store chains in the United 
Kingdom, France, Denmark, Sweden, Germany, and Switzerland…[pled] with 
growers…and shippers to separate genetically modified corn from regular corn and 
genetically modified soybeans from regular soybeans.”).   
6 Health Fears Put Future of GM Foods in Doubt, THE EXPRESS, Sept. 2, 2004, 
at 24 (discussing a recent survey for consumer magazine Which?, finding that “[f]ifty-
eight per cent [of consumers] are so concerned they try to avoid GM ingredients 
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consumer uneasiness probably arises from the average consumer’s 
lack of scientific knowledge about the sophisticated process of 
genetic engineering. In addition, people know little of the long-term 
health and environmental effects of GM foods due to the fact that 
they entered the market little over a decade ago. As a result, the 
controversy surrounding GM foods has been a hot topic in the 
international arena for the past several years. 
Genetically modified foods first entered the market in 1992. 
Since then, the agricultural industry has experienced a scientific 
breakthrough, resulting in advancements in both the quality and 
quantity of food supplies worldwide.7 GM foods are “resistant to 
pests and diseases…could grow in various environmental 
conditions,…[and are] capable of maintaining improved flavor, 
texture, shelf life, and protein content.”8 As a result of the benefits 
derived from genetic modification, GM products are more 
marketable and result in increased profits for the companies 
involved in their production and distribution. The increased 
marketability of GM foods has caused many multinational 
corporations to vigorously sponsor GE research and lobby the 
government for wider acceptance of GM foods.9 As with any profit-
driven research, many ethical, environmental, legal, and health 
concerns are often overlooked. 
There have been zealous campaigns around the world both in 
support and in opposition of GM foods.10 The issues of regulation 
and labeling have caused friction between the United States and the 
European Union (E.U.), which are engaged in a wide-ranging trade 
                                                                                                          
altogether,” and that “[s]hoppers also have no confidence in food labelling [sic], with 
sixty-one per cent convinced they are eating GM food without knowing it”). 
7 See Chineme OK Anyadiegwu, Health Risks of Genetically Modified Food: A 
Need for Unbiased Research into the Potential Health Risks of Genetically Engineered 
Crop Products, 13 SAN JOAQUIN AGRIC. L. REV. 203, 203–04 (2003); See also Julian 
Wong, Are Biotech Crops and Conventional Crops Like Products? An Analysis Under 
GATT, 2003 DUKE L. & TECH. REV. 27, ¶ 3 (2003) (“A study by the U.S. Department 
of Agriculture showed that the total pesticide use was reduced by 6.2 percent in 1997 
as a result of the use of biotechnology.” Biotechnology also results in higher crop 
yields, which means that land can be used for agricultural purposes for longer periods 
of time, thus minimizing harm to the environment.). 
8 Anyadiegwu, supra note 7, at 204.  
9 See Kim JoDene Donat, Engineering Akerlof Lemons: Information Asymmetry, 
Externalities, and Market Intervention in the Genetically Modified Food Market, 12 
MINN. J. GLOBAL TRADE 417, 423 (2003). 
10 See Michele M. Compton, Applying World Trade Organization Rules to the 
Labeling of Genetically Modified Foods, 15 PACE INT’L L. REV. 359, 360 (2003). 
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relationship with each other.11 This paper will compare the E.U. and 
U.S. approach to regulating GM products while arguing that the 
United States should adopt a labeling standard similar to that of the 
E.U. and require more consumer education and input so that 
consumers can make better informed decisions about the foods they 
purchase. Part II of this article will discuss the existing 
controversies between the United States and the European Union 
with respect to the regulation and labeling of GM foods. Next, it 
will make a comparison between the “permissive strategy”12 
adopted by the United States and the new “precautionary 
approach”13 followed by the E.U. Furthermore, Part II will 
highlight the U.S. and E.U. laws concerning GM foods and policy 
changes in view of the World Trade Organization’s (WTO) rules.  
Part III will discuss the social and political settings that affect 
the laws dealing with GM foods in different countries. Since, 
admittedly, different political and economic priorities result in 
different approaches to GM food regulation, this article will include 
an examination of the reasons for such differing attitudes towards 
biotechnology in the United States and the E.U. Furthermore, this 
article will examine the role of corporate lobbyists and consumer 
advocacy groups in pressuring U.S. and E.U. authorities to regulate 
or de-regulate the GE industry. 
Part IV will address the need for more public discussion arising 
from the fact that consumers are largely left in the dark and 
excluded from the decision-making process. Part IV will also assert 
that the lack of public involvement has resulted in decreased 
consumer confidence and that the public needs to receive more 
information and more choices in order to rebuild consumer trust.14 
In conclusion, this comment will call for the mandatory labeling of 
GM foods sold in the United States, despite scientific findings 
indicating an absence of health risks. 
 
 
11 See Terence P. Stewart & David S. Johanson, Policy in Flux: The European 
Union’s Laws on Agricultural Biotechnology and Their Effects on International 
Trade, 4 DRAKE J. AGRIC. L. 243, 246 (1999); see also Jeffrey Sparshott, U.S., EU Sue 
Each Other over Subsidies; Boeing, Airbus at Center of Market Friction, WASH. 
TIMES, Oct. 7, 2004, at C08 (stating that the United States and the European Union 
have the biggest trade partnership in the world, dealing goods and services worth over 
US$400 billion per year). 
12 Donat, supra note 9, at 427. 
13 Id.   
14 See Suh, supra note 1.  
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Safety is not the only consideration for consumers—ethics, 
morals, religion, personal beliefs, and individual preferences often 
play an important role for people in deciding what goes into their 
body. Safe or not, consumers should be able to make an informed 
decision, and adopting labeling rules will serve that purpose. 
 
II. REGULATIONS OF GENETICALLY MODIFIED ORGANISMS IN THE 
UNITED STATES AND THE EUROPEAN UNION: RECENT HISTORY 
AND THE ROLE OF THE WORLD TRADE ORGANIZATION 
  
While the regulation of genetically modified organisms (GMO) 
in the United States is tightening in response to U.S. consumer 
concerns, E.U. policies are slowly relaxing, thus giving rise to 
European consumer resistance. Historically, the U.S. government 
has been very unhappy with the E.U.’s cautious approach and has 
argued that the six-year moratorium on the importation of GM 
foods (which was lifted in April 2004) cost U.S. farmers nearly 
$300 million each year.15 In contrast, European lobbyists strongly 
favor a ban on the importation and production of GM foods and 
fear that the mixing of modified and conventional crops would limit 
the ability of consumers to avoid GM foods.16 
 
A. Regulatory Process in the United States 
 
The regulatory scheme in the United States for approving 
GMOs is well established and the process of introducing GM foods 
into the market is fairly routine, although U.S. consumers have 
challenged the entry of GM foods into U.S. markets.17 In the United 
States there is no single government agency designated to deal with 
matters of biotechnology. Instead, three different agencies regulate 
GMOs: the United States Department of Agriculture (USDA), the 
 
 
15 Paul Meller, Europe Rejects Looser Labels for Genetically Altered Food, N.Y. 
TIMES, Sept. 9, 2004, at W7, available at http://www.agobservatory.org/headlines. 
cfm?RefID=37075. 
16 See EU Approves GMO Seed for Planting Across Bloc, IRISH TIMES, Sept. 9, 
2004, at 12, available at http://www.planetark.com/dailynewsstory.cfm/newsid/27022/ 
story.htm [hereinafter EU Approves GMO Seed]. 
17 See Stewart & Johanson, supra note 11, at 246. 
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Environmental Protection Agency (EPA), and the Food and Drug 
Administration (FDA).18 
The primary role of the USDA with regard to biotechnology is 
the approval of testing, through the Animal and Plant Health 
Inspection Service (APHIS), in order to ensure the safety of new 
GMO varieties.19 APHIS issues an environmental impact statement 
and then conducts field trials to determine whether the GM 
products have any adverse effects.20 If no adverse effects are found, 
GM products gain a “nonregulated status,” meaning that they can 
be freely placed on the market and treated in the same way as non-
GMO foods.21 
The EPA conducts reviews of bio-engineered pesticides in 
order to protect public health and the environment.22 The same laws 
apply to GM food regulation as to existing similar non-GMO 
products.23 The regulation is done under the Toxic Substances 
Control Act (TSCA)24 and the Federal Insecticide, Fungicide, and 
Rodenticide Act (FIFRA).25 The purpose of TSCA and FIFRA is to 
create a comprehensive national system to protect human health 
and the environment from chemical substances including GMOs 
that contain pesticide chemicals.26 
The FDA ensures the safety of GM foods for consumption.27 
The FDA does not require safety reviews of GM foods before they 
enter the market because it considers them to be “substantially 
equivalent to conventional food.”28 Thus, as long as the end product 
 
 
18 Heather N. Ellison, Genetically Modified Organisms: Does the Current 
Regulatory System Compromise Consumer Health?, 10 PENN ST. ENVTL. L. REV. 345, 
349 (2002). 
19 Donat, supra note 9, at 428. The USDA’s authority to regulate GM foods 
stemmed from the Plant Pest Act and the Plant Quarantine Act. Both acts were 
repealed in 2000. However, the USDA continues to have authority to limit or prohibit 
the movement of GM products under the newly enacted Plant Protection Act, which is 
part of the Agricultural Risk Protection Act of 2000. Margaret Rosso Grossman, 
Biotechnology, Property Rights and the Environment, 50 AM. J. COMP. L. 215, 224 
(2002). 
20 Grossman, supra note 19, at 224.   
21 Id.  
22 Donat, supra note 9, at 428.    
23 Stewart & Johanson, supra note 11, at 247.   
24 15 U.S.C. § 2601 (2004). 
25 7 U.S.C. § 136 (2004).   
26 Grossman, supra note 19, at 224–25.  
27 Donat, supra note 9, at 428. 
28 Suh, supra note 1; Grossman, supra note 19, at 225 (explaining that since GM 
foods are not “inherently dangerous,” no approval is required before placing them on 
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is “substantially equivalent to the traditional product,” the means 
used to achieve that result is immaterial in safety determinations.29 
It is also optional for companies to consult the FDA before placing 
GM products on the market.30 The only products that require 
labeling are foods that contain common allergens.31 Nevertheless, it 
is in the manufacturers’ best interests to voluntarily undergo an 
FDA review of all products they intend to market because the FDA 
has the authority to remove unsafe products from the market and 
criminally prosecute the manufacturers of those products.32 In 
addition to not requiring pre-market approval, the United States has 
                                                                                                          
the market); Starla L. Borg, Waiting for the River: The United States and European 
Union, Heads Up and High Strikes in the WTO–Genetically Modified Organisms in 
International Trade, 43 WASHBURN L.J. 681, 715 (2004); see also Matthew Rich, The 
Debate over Genetically Modified Crops in the United States: Reassessment of 
Notions of Harm, Difference, and Choice, 54 CASE W. RES. L. REV. 889, 902 (2004) 
(“[T]he FDA has stated that there is no material difference in nutrition, composition, 
or safety between genetically modified food and non-modified food.”). 
29 Donat, supra note 9, at 428. Bioengineers add fish genes to tomatoes to 
prolong their freshness. Since a genetically modified tomato did not become “fish-
like” and still “looks and tastes like a tomato,” the FDA states that “the only 
information that will be provided to the consumer is that which is traditionally 
provided with tomatoes.” See also Katharine Van Tassel, The Introduction of Biotech 
Foods to the Tort System: Creating a New Duty to Identify, 72 U. CIN. L. REV. 1645, 
1655 (2004).   
30 Stewart & Johanson, supra note 11, at 248; Grossman, supra note 19, at 225 
(stating that the FDA implemented a “voluntary consultation process,” giving 
companies an opportunity to determine whether the GM food possesses unusual 
attributes or substances that would warrant the need for approval of such foods before 
they are placed on the market).   
31 Kim Brooks, History, Change and Policy: Factors Leading to Current 
Opposition to Food Biotechnology, 5 GEO. PUB. POL’Y REV. 153, 153 (2000). 
However, GMOs may contaminate conventional crops that do not pose a risk of 
allergies and thus create allergic reactions in people who consume foods produced 
from such contaminated crops. See Wong, supra note 7, ¶ 4 (providing as an example 
a year 2000 incident, when U.S. grocery stores had to recall taco shells “found to 
contain genetically modified corn that was unapproved for human consumption due to 
the possible allergic reactions”). In 2001, the Wall Street Journal reported that out of 
twenty products labeled as “non-GMO,” sixteen contained traces of genetic 
modification. The reason for this is that “some genetically modified crops—which 
have been designed to resist disease, pests and chemicals—can cross-pollinate freely 
with regular crops, passing along their altered traits to the next generation.” Neil E. 
Harl, Biotechnology Policy: Global Economic and Legal Issues, 12 WILLAMETTE J. 
INT’L L. & DISP. RES. 1, 14 (2004) (quoting Patricia Callahan & Scott Kilman, Seeds of 
Doubt: Some: Ingredients Are Genetically Modified, Despite Labels’ Claims, THE 
WALL ST. J., Apr. 5, 2001, at 17). 
32 Stewart & Johanson, supra note 11, at 248–49. 
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declined to require labeling.33 This regulatory scheme has become 
known as the permissive strategy.34 
Unfortunately, the U.S. government enthusiastically welcomed 
GM foods without first considering the potential problems they 
may cause.35 In accordance with the permissive strategy, 
manufacturers often place foods derived from biotechnology on the 
market before any thorough testing takes place, and government 
agencies remove these foods from the market only after they find 
them unsafe.36 For example, the long-term effects of many 
transgenic crops, such as soybeans and corn, underwent research 
and safety testing only after the widespread commercialization of 
such crops.37 The lack of research and the potential harmful effects 
 
 
33 See Suh, supra note 1 (stating that since the FDA considers GM foods to be 
“substantially equivalent to conventional food,” there is no requirement for 
manufacturers to label GM foods as such).   
34 See Donat, supra note 9, at 428. 
35 Some of the potential problems that arise from genetic modification of foods 
include:  
(1) Inadvertent creation of new allergens. “[K]nown allergens could be 
transferred from traditional foods into GM foods.”  
(2) Development of resistance to antibiotics. Bioengineers sometimes insert 
marker genes into GM foods to help bioengineers determine “whether a new gene has 
been successfully introduced to the host DNA.” If humans consume marker genes 
coded for resistance to particular antibiotics, “the effectiveness of antibiotics could be 
reduced and human infectious disease risk increased.” 
(3) Cross-breeding. Cross-breeding between GM crops and surrounding 
vegetation “could result in weeds that are resistant to herbicides and would thus 
require a greater use of herbicides, which could lead to soil and water contamination.” 
(4) Pesticide resistant insects. “[T]he genetic modification of some crops to 
permanently produce the natural biopesticide Bacillus thuringiensis (Bt) toxin could 
encourage the evolution of Bt-resistant insects, rendering the spray ineffective.”  
(5) Biodiversity. “[G]rowing GM crops on a large scale may also have 
implications for biodiversity, the balance of wildlife and the environment.” 
(6) Cross-contamination. “[P]lants bioengineered to produce pharmaceuticals 
(medicines, e.g.) may contaminate food crops.” 
GM foods also present numerous ethical, religious, and philosophical concerns. 
Better Health Channel, Genetically Modified Foods, http://www.betterhealth.vic.gov. 
au/bhcv2/bhcarticles.nsf/pages/Genetically_modified_foods (last visited Mar. 25, 
2006).   
36 Brian Halweil, Portrait of an Industry in Trouble, WORLDWATCH INST., Feb. 
17, 2000, http://www.worldwatch.org/press/news/2000/02/17/. 
37 Id. (stating that only after more than half of the U.S. soybeans and corn were 
already genetically engineered, the U.S. Secretary of Agriculture, Dan Glickman, 
stated the need for long term effects of these crops on human health and the 
environment).   
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of GM foods before they enter the market show an alarmingly 
deficient regulatory method.  
 
B. Regulations in the European Union 
 
In contrast to the permissive approach of the United States, the 
E.U. has adopted a precautionary approach that “defines genetic 
modification based on the process rather than product.”38 Therefore, 
under this precautionary approach, if a crop is genetically modified 
to have a longer shelf life, it is defined as genetically modified even 
though it is substantially equivalent to the genetically unmodified 
product. The precautionary approach has emerged from opposition 
to the strong support of GM foods from the United States.39 
Another fundamental difference between the permissive strategy 
and the precautionary approach is that “[i]nstead of requiring critics 
to prove that a technology poses potential dangers, the producers of 
the technology shoulder the burden of presenting evidence that the 
technology is safe.”40  
As part of the precautionary strategy, the E.U. mandates 
labeling of all GM products, a controversial subject that U.S. 
officials view as an illegal barrier to trade.41 In fact, the United 
States brought a complaint against the E.U. before the WTO 
settlement committee addressing this matter.42 Brian Halweil, 
speaking about the precautionary approach and the U.S. position 
toward it, states: 
 
Industry has long labeled the precautionary 
approach as reactionary, arguing that it stifles 
research and prevents economic progress. On the 
contrary, advocates realize that all stakeholders[–
]including consumers, government, and industry[–] 
benefit from an open and democratic attempt to 
anticipate any undesirable social and financial 
surprises. The goal is to apply wisdom and 
 
 
38 Donat, supra note 9, at 429. 
39 Michelle K. McDonald, International Trade Law and the U.S.-EU GMO 
Debate: Can Africa Weather This Storm?, 32 GA. J. INT’L & COMP. L. 501, 504 (2004). 
40 Halweil, supra note 36. 
41 Elizabeth Suh, Opposing Views on GE Food Review, Labeling, WASH. TIMES, 
Sept. 2, 2004, available at http://washingtontimes.com/upi-breaking/20040823-
033223-4180r.htm. 
42 Id.  
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judgment about the potential effects of a new 
technology before flooding the marketplace with the 
products of that technology.43  
  
The E.U. achieves its regulation of GM foods through the legal 
framework that incorporates provisions of the U.N. Codex 
Alimentarius (Codex), the Cartagena Protocol to the Convention on 
Biological Diversity (Cartagena Protocol), the Organization for 
Economic Cooperation and Development Working Parties on 
Safety of Novel Foods (OECD), and the WTO.44 The Food and 
Agriculture Organization of the United Nations (FAO) and the 
World Health Organization (WHO) jointly created the Codex to 
develop standards for food safety and ensure fair trade practices.45    
The Cartagena Protocol, enacted in 2003, is an international 
agreement that establishes rules and regulations for GMO trade to 
protect human health and the environment.46 The agreement insists 
that countries research genetically altered organisms and assess 
possible risks prior to releasing such products into the market.47 
One hundred and thirty U.N. member nations have ratified the 
Cartagena Protocol,48 which entered into force as a result of the 
 
 
43 Halweil, supra note 36. 
44 Compton, supra note 10, at 366. International policymakers “have attempted 
to fit square pegs into round holes, applying existing trade law to the novel features of 
biotechnology.” Wong, supra note 7, ¶ 2. 
45 Codex Alimentarius, http://www.codexalimentarius.net/web/index_en.jsp (last 
visited Mar. 7, 2006) [hereinafter Codex].   
46 See Sara J. MacLaughlin, Food for the Twenty-First Century: An Analysis of 
Regulations for Genetically Engineered Food in the United States, Canada, and the 
European Union, 14 IND. INT’L & COMP. L. REV. 375, 402-03 (2003). The Cartagena 
Protocol has the following objective: 
 
[T]o contribute to ensuring an adequate level of protection in the 
field of the safe transfer, handling and use of living modified 
organisms resulting from modern biotechnology that may have 
adverse effects on the conservation and sustainable use of 
biological diversity, taking also into account risks to human 
health, and specifically focusing on transboundary movements.  
 
Cartagena Protocol on Biosafety to the Convention on Biological Diversity, art. 
1, Jan. 29, 2000, http://www.biodiv.org/biosafety/protocol.asp (last visited Mar. 7, 
2006) [hereinafter Cartagena Protocol]. The term living modified organism (LMO) is 
interchangeable with genetically modified organism (GMO).  
47 MacLaughlin, supra note 46, at 403.  
48 The Cartagena Protocol has been ratified by thirty-seven African countries, 
thirty-three countries of Asia and the Pacific, nineteen countries in Central and Eastern 
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U.N. Convention on Biological Diversity; the United States 
participated in the creation of the Convention on Biological 
Diversity and signed it but has not ratified it.49 Nearly all nations 
are parties to the Convention on Biological Diversity, which 
negotiated the Cartagena Protocol.50 This protocol reiterates the 
precautionary principle,51 embraced by European countries, that 
permits countries to enact trade restrictions to avoid the adverse 
effects of GMOs, even in the absence of scientific certainty with 
respect to such potential adverse effects.52 
The E.U. regulations governing GM products of direct interest 
to the United States include Council Directive 90/220 (replaced by 
2001/18/EC), which concerns “GMO products that may be 
described as raw materials,” and Council Regulation 258/97, which 
                                                                                                          
Europe, twenty-three countries in Latin America and the Caribbean, and twenty 
countries in Western Europe and other regions. Convention on Biological Diversity, 
May 15, 2000, Cartagena Protocol on Biosafety (Montreal, 29 January 2000): Status 
of Ratification and Entry into Force, http://www.biodiv.org/biosafety/signinglist. 
aspx?sts=rtf&ord=dt (last visited Mar. 22, 2006).   
49 Id. Ratification occurs when a State “establishes on the international plane its 
consent to be bound by a treaty.” Vienna Convention on the Law of Treaties, 22 May 
1969, 1155 U.N.T.S. 331, 8 I.L.M. 679, 681. The concept of ratification provides the 
states with the “necessary time-frame to seek the required approval for the treaty on 
the domestic level and to enact the necessary legislation to give domestic effect to that 
treaty.” United Nations Treaty Collection: Treaty Reference Guide, ¶18, 
http://untreaty.un.org/English/guide.asp (last visited Mar. 22, 2006).   
50 Olivette Rivera-Torres, The Biosafety Protocol and the WTO, 26 B.C. INT’L & 
COMP. L. REV. 263, 263, 269 (2003) (stating that 186 countries are parties to the 
Convention on Biological Diversity). 
51 The Cartagena Protocol integrates precautionary principle through the 
following language: 
 
Lack of scientific certainty due to insufficient relevant scientific 
information and knowledge regarding the extent of the potential 
adverse effects of a living modified organism on the conservation 
and sustainable use of biological diversity in the Party of import, 
taking also into account risks to human health, shall not prevent 
that Party from taking a decision, as appropriate, with regard to the 
import of the living modified organism in question…in order to 
avoid or minimize such potential adverse effects. 
 
Cartagena Protocol, supra note 46, art. 10. 
52 The Cartagena Protocol permits countries to limit or even prohibit the 
importation of GMOs. The provision authorizing countries to restrict the importation 
of GMOs has raised a controversy because the importing nations regard it as a barrier 
to trade. Patrick J. Vallely, Tension Between the Cartagena Protocol and the WTO: 
The Significance of Recent WTO Developments in an Ongoing Debate, 5 CHI. J. INT’L 
L. 369, 372 (2004). 
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concerns “‘novel foods,’ including foods containing GMOs.”53 The 
purpose of Council Directive 2001/18/EC is to protect human 
health and the environment in accordance with the precautionary 
principle.54 It aims to accomplish that objective by “controlling 
risks from the deliberate release into the environment of genetically 
modified organisms….”55 The Directive requires notification before 
the deliberate release of a GMO.56 It also contains a safeguard 
procedure under which member states may deny consent to GM 
products.57 If a member state objects to the release of GMOs, it 
should submit a proposed measure to a scientific committee to 
evaluate adverse effects on human health and the environment.58 
The committee, “composed of individuals from all member states[,] 
advises the Commission, and voting is [done] by qualified 
majority.”59 The Council and the Parliament resolve any 
disagreements that may arise.60 It is very important to consider that, 
unlike the completely nontransparent U.S. regulations, the E.U. 
Directive requires the states to consult the public about the intended 
releases and give consumers an opportunity to voice their 
opinions.61 Regular consumer opposition, which strives for tougher 
regulation, often clashes with the anxieties of the member states’ 
governments that struggle to stay competitive in the field of 
biotechnology. As a result, the laws frequently change and there is 
no conclusive strategy.62  
 Council Regulation 258/97 ensures that GM foods are safe, not 
misleading, and not “nutritionally disadvantageous” to consumers.63 
The regulation achieves this objective through pre-market safety 
 
 
53 Stewart & Johanson, supra note 11, at 256; Johannes S.A. Claus III, The 
European Union’s Efforts to Sidestep the WTO Through Its Ban on GMOs: A 
Response to Sarah Lively’s Paper, “The ABCs and NTBs of GMOs,” 24  NW. J. INT’L 
L. & BUS. 173, 178 (2003) (describing European Union’s Directives and Regulations 
that emerged in recent years in response to adverse public opinion with respect to 
biotechnology).  
54 Council Directive 2001/18/EC, art. 1, 2001 O.J. (L 106) 1 [hereinafter Council 
Directive 2001/18]. 
55 Id. at (5) Preamble.  
56 Council Directive 2001/18, supra note 54, art. 6. 
57 Borg, supra note 28, at 717. 
58 Council Directive 2001/18, supra note 54, art. 28.  
59 Borg, supra note 28, at 718. 
60 Id.  
61 Council Directive 2001/18, supra note 54, art. 9. 
62 See Stewart & Johanson, supra note 11, at 246–47. 
63 Council Regulation 258/97/EC, art. 3, 1997 O.J. (L 043) 1. 
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assessments of novel foods before placing them on the market.64 
Furthermore, the regulation sets out the specific labeling 
requirements that apply to GM foods.65 The regulation puts U.S. 
exporters in distress because meeting the traceability and labeling 
requirements is too burdensome under the permissive regulatory 
system that exists in the United States.66  
 
C. Recent Developments in the United States 
 
In recent years, the United States has experienced a number of 
developments in the area of GMO regulation, including the 
formation of a Biotechnology Advisory Committee to review 
testing and approval procedures.67 The EPA is doing a similar 
review.68 There were also several lawsuits filed addressing the 
developments in biotechnology. For example, a suit filed by 
Greenpeace against the EPA was dismissed, and another suit 
opposing the FDA’s approval of genetically altered organisms 
resulted in a summary judgment for the government.69 Legislators 
have also become increasingly involved in the decision-making 
process regarding the regulation of GM foods.70  
In 2000, President Clinton formed the U.S.-E.U. Biotechnology 
Consultative Forum, consisting of “representatives of consumer 
groups, academia, and industry from the United States and the 
European Union,” to make recommendations regarding the 
regulation of GM foods.71 The panel issued a report, recommending 
“safety reviews and mandatory labeling for GMOs,” which resulted 
in amplified demands to increase the regulation of the GM industry 
and biotechnology as a whole.72  
During the 2004 Presidential Campaign, President George W. 
Bush and his challenger, Senator John F. Kerry, highlighted their 
 
 
64 Id. at (2) Preamble.  
65 Id. at art. 8.  
66 Marsha Echols, Bioethics Symposium: National and Global Implications of 
Genetically-Modified Organisms: Law, Ethics & Science: The WTO Biotechnology 
Dispute, 34 CUMB. L. REV. 445, 445–46 (2003–04) (“While the dispute primarily pits 
the United States against the European Communities, the debate in reality involves the 
world and will not be resolved by these cases.”). 
67 Ellison, supra note 18, at 353. 
68 Id.  
69 Id.  
70 Id. at 360. 
71 Id. at 361. 
72 Id. at 361–62. 
SPRING 2006 Genetically Modified Foods 
 
323 
differences on the issue of genetically modified crops.73 In 
discussing the regulation of GMOs, Bush stressed the importance 
of the “regulatory framework [that] keeps pace with science,” while 
Kerry shared his plan to “give government agencies the power to 
effectively regulate genetically modified food products.”74 Mindful 
of the fact that the United States produces the vast majority of the 
world’s genetically modified foods, President Bush argued to 
protect U.S. farmers and opposed the labeling of products derived 
by means of biotechnology.75 U.S. farmers largely use GM crops; 
thus, the non-restrictive regulation of GM foods means higher 
revenues for the farmers exporting GM crops. Conversely, 
restrictions on the use of GM foods make it hard for U.S. farmers to 
sell GM foods in Europe, which ends up costing U.S. farmers 
millions of dollars annually.76 The approach that President Bush 
argued for mirrored his father’s (former President Bush) strategy of 
not requiring companies to conduct safety testing on GM foods.77 
Kerry, on the other hand, promised to greatly increase government 
efforts to ensure that genetically modified products are safe for 
consumers as well as the environment.78 Since President Bush has 
been re-elected for his second term, his policies regarding GM 
foods are currently in place.  
 
D. Recent Developments in the European Union 
 
In 2004, European scientists concluded that GM foods are safe 
for human consumption.79 Pursuant to that conclusion, in April 
 
 
73 Campaign 2004 II: Bush, Kerry Face Off in Science Questionnaire, 
GREENWIRE, Sept. 16, 2004, at Politics Vol.10 No.9. 
74 Id. 
75 Kevin Diaz, Minnesota’s Top Issues Agriculture: Farming, Biotechnology and 
Trade; The Records, Opinions and Plans of the Two Leading Presidential Candidates, 
STAR TRIB., Oct. 20, 2004, at 17A (stating that while GM foods yield large revenues to 
American farmers, there are safety concerns associated with production and 
consumption of such foods in parts of South America, Africa and Europe).  
76 Brandon Mitchener, Scott Kilman & Scott Miller, EU Court Upholds Italy’s 
Ban on Genetically Modified Food, WALL ST. J., Sept. 9, 2003, available at 
http://www.mindfully.org/GE/2003/EU-Italy-Ban-GMO9sep03.htm. 
77 Hart, supra note 5, ¶ 8.  
78 Diaz, supra note 75 (Kerry promised to push for acceptance of American 
exports of GM foods and mindful of safety concerns, “Kerry has also criticized the 
Europeans and others who he says should not use safety as a ‘pretext’ to close their 
markets to U.S. exports.”). 
79 Meller, supra note 15.  
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2004, the European Commission lifted a moratorium on the 
importation of GM foods that had been in effect for the past six 
years.80 However, the E.U. remains firm on the labeling issue, and 
prior to lifting the moratorium, the European Commission passed 
strict laws mandating labeling of GM foods.81 The new regulations 
include Regulation (EC) No. 1829/2003, dealing with GM food and 
feed, and Regulation (EC) No. 1830/2003, dealing with traceability 
and labeling of GM foods.82 The objective of both regulations is to 
“protect the environment, human and animal welfare 
and…consumer choice.”83  
In September 2004, the E.U., for the first time, approved the 
planting and selling of certain seeds derived by biotechnological 
means in Europe.84 The E.U. made the decision in spite of 
widespread opposition by European consumers.85 Nevertheless, 
support for GM foods in the E.U. continues to grow. The Danish 
nominee for the post of the European Agriculture Commissioner, 
Mariann Fischer Boel, expressed her support for both GM and 
conventional (including organic) foods by stating that “no form of 
agriculture (GMO or non-GMO) should be excluded in the EU in 
the future.”86  
 
E. The Role of the World Trade Organization 
 
Existing regulations cannot keep up with rapidly developing 
technology. Because neither the supporters nor the opponents of 
GM foods are willing to give in, there is a great need for a 
common-ground, international regulatory scheme that would take 
both the objectives of international trade and the need to protect 
human health and the environment into consideration. 
Traditionally, these two interests have clashed, and therefore “the 
question which must be addressed by future policy makers is not 
 
 
80 Id.  
81 Id.  
82 Brian Schwartz, Student Note, WTO and GMOs: Analyzing the European 
Community’s Recent Regulations Covering the Labeling of Genetically Modified 
Organisms, 25 MICH. J. INT’L L. 771, 781 (2004). Both regulations went into effect on 
April 18, 2004. Regulation (EC) No. 1829/2003 preempts the provisions of the 
Council Regulation 258/97 (Novel Foods Regulations) that deal with GM foods. Id.  
83 Id. at 783. 
84 EU Approves GMO Seed, supra note 16.  
85 Id.  
86 Sara Lewis, Incoming EU Farm Commissioner Calls for Biotech Coexistence, 
46 FOOD CHEMICAL NEWS, Sept. 27, 2004, at 10.   
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which aspect should prevail, but rather how to create harmony 
between the two.”87 Achieving such balance will not be easy, but 
because the industry is so new, there is “a unique opportunity to 
tailor regulatory requirements closely to the needs of the time and 
to find a sensible balance between the concerns of the industry, 
government, science, and the public.”88 The organization that 
should play a central role in achieving a higher level of 
understanding between the advocates and the critics is the WTO.  
The WTO has established procedures by which countries can 
notify it if certain measures taken by member states may potentially 
affect international trade.89 If such measures are in violation of 
WTO trade rules, the WTO may impose trade sanctions.90 Two 
mutually exclusive WTO agreements deal with GM foods: the 
Agreement on the Application of Sanitary and Phytosanitary 
Measures (SPS Agreement), and the Agreement on Technical 
Barriers to Trade (TBT Agreement).91 The goal of the TBT and SPS 
Agreements is to advance trade and expound the General 
Agreement on Tariffs and Trade (GATT).92 
The SPS Agreement was implemented in 1995 to prevent 
certain scientifically unfounded safety measures from impeding the 
trade of food products.93 While the SPS Agreement “permits 
countries to maintain SPS measures necessary to protect human, 
animal, and plant life and health,” it also facilitates trade by 
requiring that such protective measures are not used “as disguised 
barriers to trade.”94 The SPS Agreement promotes conformity of 
national measures with international standards and encourages 
 
 
87 Jennifer A. Bernazani, The Eagle, the Turtle, the Shrimp and the WTO: 
Implications for the Future of Environmental Trade Measures, 15 CONN. J. INT’L L. 
207, 208 (2000). 
88 Frederick H. Degnan, The Food Label and the Right-to-Know, 52 FOOD & 
DRUG L.J. 49, 49 (1997).   
89 Compton, supra note 10, at 372. 
90 Id. at 372–73 
91 Id. at 373–74. 
92 Norbert L.W. Wilson, Clarifying the Alphabet Soup of the TBT and the SPS in 
the WTO, 8 DRAKE J. AGRIC. L. 703, 705 (2003). 
93 Terence P. Stewart & David S. Johanson, A Nexus of Trade and the 
Environment: The Relationship Between the Cartagena Protocol on Biosafety and the 
SPS Agreement of the World Trade Organization, 14 COLO. J. INT’L ENVTL. L. & 
POL’Y 1, 25 (2003).   
94 Id.  
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countries to enact measures based on an international standard.95 
The SPS Agreement also provides for another way of establishing 
SPS measures by basing them on risk assessment.96 Risk 
assessment bases itself on the following factors: “available 
scientific evidence; relevant processes and production methods; 
relevant inspection, sampling and testing methods; prevalence of 
specific diseases or pests; existence of pest- or disease-free areas; 
relevant ecological and environmental conditions; and quarantine or 
other treatment.”97 Lastly, countries can also enact provisional SPS 
measures “on the basis of available pertinent information.”98  
The TBT Agreement “encourages the development of 
international regulatory standards” and prevents deceptive 
practices.99 It requires that measures “are not applied in a manner 
 
 
95 Id. at 26. Scientific justifications may warrant higher standards that are stricter 
than the international norm. Borg, supra note 28, at 689. Under the SPS Agreement, 
scientific justifications also permit countries to implement measures that are “neither 
based on, nor exceed international standards.” Rivera-Torres, supra note 50, at 296. 
96 Article Five of the SPS Agreement provides: “[m]embers shall ensure that 
their sanitary or phytosanitary measures are based on an assessment, as appropriate to 
the circumstances, of the risks to human, animal or plant life or health, taking into 
account risk assessment techniques developed by the relevant international 
organizations.” The WTO Agreement on the Application of Sanitary and 
Phytosanitary Measures, Apr. 15, 1994, art. 5(1), http://www.wto.org/English/tratop_ 
e/sps_e/spsagr_e.htm (last visited Mar. 22, 2006) [hereinafter SPS Agreement]. 
97 Id. at art. 5(2).  
98 Article Five of the SPS Agreement provides:  
 
In cases where relevant scientific evidence is insufficient, a 
Member may provisionally adopt sanitary or phytosanitary 
measures on the basis of available pertinent information, including 
that from the relevant international organizations as well as from 
sanitary or phytosanitary measures applied by other Members. In 
such circumstances, Members shall seek to obtain the additional 
information necessary for a more objective assessment of risk and 
review the sanitary or phytosanitary measure accordingly within a 
reasonable period of time. 
 
Id. at art. 5(7).     
99 Borg, supra note 28, at 693. The TBT Agreement sets the following standards:  
 
Members shall ensure that technical regulations are not prepared, 
adopted or applied with a view to or with the effect of creating 
unnecessary obstacles to international trade. For this purpose, 
technical regulations shall not be more trade-restrictive than 
necessary to fulfil [sic] a legitimate objective, taking account of 
the risks non-fulfilment [sic] would create. Such legitimate 
objectives are, inter alia: national security requirements; the 
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[that] would constitute a means of arbitrary or unjustifiable 
discrimination between countries where the same conditions prevail 
or a disguised restriction on international trade.”100 Risk assessment 
under the TBT Agreement shall base itself on the following factors: 
“available scientific and technical information, related processing 
technology or intended end-uses of products.”101 Article 1.5 of the 
TBT Agreement limits its scope by stating that the agreement does 
not apply to sanitary and phytosanitary102 measures, thus making 
the TBT and the SPS Agreements mutually exclusive.103  
The GATT, first signed in 1947, regulates tariffs on goods and 
provides a forum for settling trade disputes, thus encouraging free 
trade between member states.104 The framework for free trade under 
GATT is built upon the following three principles: “prohibiting 
discrimination between the products imported by member states,” 
“prohibiting discrimination between imported and domestic goods,” 
and “prohibiting quantitative restrictions on trade.”105 GATT 
Article XX sets forth general exceptions to unrestricted trade, 
which include measures “necessary to protect human, animal or 
plant life or health.”106 However, even if the exception is made in 
accordance with Article XX provisions, it still “shall not depart 
from the provisions of this Agreement relating to non-
discrimination.”107 
Clearly, all WTO agreements aim at facilitating trade and 
requiring countries to restrain from imposing measures that will 
                                                                                                          
prevention of deceptive practices; protection of human health or 
safety, animal or plant life or health, or the environment. 
 
Agreement on Technical Barriers to Trade, Apr. 15, 1994, 
http://www.worldtradelaw.net/uragreements/tbtagreement.pdf (last visited Mar. 25, 
2006) [hereinafter TBT Agreement]. 
100 Id. at Preamble.  
101 Id. at art. 2.2.  
102 Phytosanitary is defined by Merriam-Webster as “of, relating to, or being 
measures for the control of plant diseases especially in agricultural crops.” 
103 Article 1.5 of the TBT Agreement reads: “[t]he provisions of this Agreement 
do not apply to sanitary and phytosanitary measures as defined in Annex 4 of the 
Agreement on Application of Sanitary and Phytosanitary Measures.” TBT Agreement, 
art. 1.5.   
104 See Rivera-Torres, supra note 50, at 289.  
105 See id. 
106 General Agreement on Tariffs and Trade, Oct. 30, 1947, 61 Stat.A-11, 55 
U.N.T.S. 194 at art. XX., available at http://www.ciesin.org/TG/PI/TRADE/gatt.html 
(last visited Mar. 22, 2006) [hereinafter GATT].    
107 Id. at XX(i). 
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restrict the transboundary movement of goods.108 Conversely, the 
Cartagena Protocol, concerned with the environment, requires 
states to take affirmative steps to regulate GMOs appropriately in 
ways that ensure the preservation of biodiversity.109 As a result, 
there is a risk that measures enacted under the Cartagena Protocol 
would deviate from the WTO rules. To prevent measures enacted 
under the Cartagena Protocol from being invalidated as 
unreasonable barriers to trade, such measures must comply with the 
international standards provided for by the WTO.110 Moreover, 
when disputes are resolved through the WTO Dispute Settlement 
Procedures, “environmental treaties may be invalidated as trade 
barriers, as they are not considered when all GATT parties have not 
approved of their recognition.”111 
In 2001, the Commission of the European Community proposed 
regulations “concerning traceability and labelling [sic] of 
genetically modified organisms.”112 The objectives of the proposed 
regulations are to facilitate quality control, to provide a “safety net” 
in all stages of production and marketing, and to create mechanisms 
for removing unsafe foods from the market.113 The proposal also 
creates a framework for controlling labeling and verifying claims 
made on food labels.114 The proposed regulations “provide legal 
 
 
108 See Rivera-Torres, supra note 50, at 302. 
109 Id.  
110 Borg, supra note 28, at 696 (stating that unless environmental measures are 
enacted in accordance with the international standard recognized by the WTO, “the 
environmental mission may be seen as irrelevant and, in some instances, as an 
obstruction to free trade”). 
111 Id.  
112 Commission Proposal for a Regulation of the European Parliament and of 
the Council Concerning Traceability and Labelling [sic] of Genetically Modified 
Organisms and Traceability of Food and Feed Products Produced from Genetically 
Modified Organisms and Amending Directive 2001/18/EC, at 9, COM (2001) 182 
final (July 25, 2001), available at http://europa.eu.int/comm/food/fs/biotech/ 
biotech09_en.pdf [hereinafter Proposal for Traceability and Labeling of GMOs]. In 
the explanatory section of the proposal, it is recognized that disparities between laws 
of different exporting and importing countries with regard to GM food regulation 
“may hinder the free movement of products, creating conditions of unequal and unfair 
competition.” The proposal remedies this problem by creating a coherent and 
consistent framework for tracing and labeling GM foods. Id. 
113 The traceability requirements allow for continued tracking of products 
containing GMOs and ensure that such information is retained through every stage of 
placing the product of the market and never discontinued. Id. at 8. 
114 All GM products placed on the market have to carry a label saying “[t]his 
product contains genetically modified organisms.” In the case of impossibility of 
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certainty for traders” and ensure “that ethical, legal, social and 
wider cultural aspects are taken into account in policy-making and 
research funding.”115  
The United States did not favor the proposal, and in a secret 
document sent to the WTO, the United States subjected it to vast 
criticism calling into question the majority of its objectives.116 The 
United States expressed concerns that the proposed regulation was 
“not workable or enforceable, would be very expensive to 
implement, and would not achieve the stated objectives.”117 The 
United States opposed labeling on the grounds that it would do 
“nothing to ensure food safety,” would “encourage[] fraudulent 
labelling [sic] claims,” and “would undermine consumer 
confidence.”118 Moreover, the proposed regulation “would be 
disastrous for U.S. farmers” and would “disrupt market access from 
Europe’s major trading partner and from developing countries, 
again stifling development of the technology.”119  
                                                                                                          
placing a label directly on a product, appropriate documentation should accompany 
the product. Id. at 7. 
115 Biotechnology: National Rules to Resolve Problem of Co-Existence of Crops, 
EUROPEAN REPORT, Mar. 8, 2003, at 3.  
116 See U.S. Comments: Proposal for a Regulation of the European Parliament 
and of the Council Concerning Traceability and Labeling of Genetically Modified 
Organisms and Traceability of Food and Feed Products from Genetically Modified 
Organisms and Amending Directive 2001/18/EC (Dec. 6, 2001), available at 
http://www.foeeurope.org/press/USG_comments_G_TBT_N_EEC_7.pdf [hereinafter 
U.S. WTO TBT Response].   
117 Id. Consider the following example: 
 
A medium sized food company can have more than 6,000 products 
that contain 8,000 ingredients from 1,000 suppliers that move 
through 30 processing plants on their way to being exported to as 
many as 100 countries. Implementing a system to track all of these 
ingredients from their source (as far back as to the farm) to the 
final destination is a daunting task that would cost billions of 
dollars and even then it may not be infallible. 
 
Mystery Bridges, Genetically Modified Organisms and the Precautionary 
Principle: How the GMO Dispute Before the World Trade Organization Could Decide 
the Fate of International GMO Regulations, 22 TEMP. ENVTL. L. & TECH. J. 171, 178 
(2004).  
118 Press Release, Friends of the Earth, U.S. Steps up the Pressure on EU GMO 
Legislation (Jan. 16, 2002), available at http://www.genet-info.org/genet/2002/Jan/ 
msg00021.html [hereinafter EU GMO Legislation].    
119 Alan Larson, The Future of Agricultural Biotechnology in World Trade: The 
Promise and Challenges, Feb. 21, 2002, http://www.state.gov/e/rls/rm/2002/8447.htm. 
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Instead, the United States favors a less restrictive system that it 
has followed for years.120 Under that system, instead of 
communicating the biotech information to all the recipients of the 
GM products, such products would simply be recalled from the 
market if a valid safety concern arose.121 In other words, the United 
States considers foods derived from biotechnology to be safe until 
proven harmful.122 Labeling, in the view of the United States, is too 
burdensome, and it is not in any country’s interest because it 
“encourages fraudulent claims.”123 Moreover, the United States 
argues that this regulation would do nothing to protect consumers 
and instead would “discourage trade and increase delays and 
liability costs for exporters, EU importers, and processors.”124  
The U.S. criticism of the proposed regulation caused a huge 
wave of frustration and resentment in the European countries.125 
Friends of the Earth food campaigner, Adrian Bebb, expressed this 
intensifying sentiment in response to the U.S. comments: 
 
The Bush Administration is trying to take away our 
right to decide on GM food. The public has made it 
very clear that they want proper labelling [sic] and 
proper testing for GM foods. The proposed EU laws 
are at least a step in the right direction. The US 
wants to weaken these laws to protect the likes 
of…American agri-business. European countries 
must refuse to bow to this bullying. European 
citizens demand the right to choose.126 
 
 
 
120 See U.S. WTO TBT Response, supra note 116. 
121 Id. 
122 Halweil, supra note 36 (discussing the fundamental differences between the 
permissive approach, applied in the United States, and the precautionary principle, 
followed in Europe and many other countries, with respect to GM food regulation). 
123 U.S. WTO TBT Response, supra note 116. 
124 Id. 
125 See EU GMO Legislation, supra note 118.  
126 Press Release, Friends of the Earth, U.S. Steps Up Pressure on GM Food: US 
Threatens the Public’s Right to Choose on GM Food (Jan. 16, 2002), available at 
http://www.foe.co.uk/resource/press_releases/20020116125140.html. European consu-
mers are not the only ones demanding the right to choose. In addition to the E.U. 
member countries, Japan, South Korea, Australia, Mexico, and other nations enacted 
laws mandating labeling of foods containing genetically modified ingredients. 
Halweil, supra note 36. 
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The U.S. view focuses more on the development and marketing 
of biotechnology rather than on testing for possible risks it may 
pose, which demonstrates misplaced priorities and poor planning.127 
The position of the E.U. is that it “should not have to suffer for 
incorporating the precautionary principle into its regulation from 
the beginning simply because of decisions made by the [United 
States].”128  
The disputes involving WTO regulations are settled through the 
well-established WTO Dispute Settlement Process.129 Although the 
WTO usually favors U.S., European, and Japanese businesses, there 
is a growing concern that it tends to render more support to the 
United States than to other countries. As a result, European 
corporations are having a harder time trying to produce safer 
foods.130 In fact, some have accused the WTO of being a “cat’s paw 
of the United States government” for frequently siding with U.S. 
businesses in spite of disapproval of European resistance to 
GMOs.131  
Recently, at the request of the United States, Canada, and 
Argentina, the WTO agreed to investigate the E.U.’s position on 
GMOs.132 The WTO organized a three-judge panel in August 
2003133 and should have issued its report on January 5, 2006.134 
However, two days before the panel issued its scheduled report, the 
panel’s chair announced that the interim preliminary report would 
 
 
127 Bridges, supra note 117, at 178–79.  
128 Id. at 179.  
129 Stewart & Johanson, supra note 93, at 26. Among the disputes involving SPS 
measures, “three…have reached the Dispute Settlement Body, five are pending 
consultations, and two have been settled.” Id. 
130 See Anup Shah, A Huge Wave of Public Concern, http://www.globalissues. 
org/EnvIssues/GEFood/PublicReaction.asp (last visited Mar. 23, 2006). 
131 John Moore, John Moore Urges Us to Assert Our Right to Economic and 
Cultural Diversity and Stand Up to the Unaccountable WTO, MORNING STAR, Oct. 4, 
2004, at 9. 
132 Europe Reflects Italian Battle over Biotech Coexistence, ANSA ENGLISH 
MEDIA SERVICE, Oct. 13, 2004, 2004 WL 86476169 [hereinafter Europe Reflects 
Italian Battle]. In response to the moratorium on the importation of GMOs imposed by 
the E.U., the United States, joined by Argentina and Canada, initiated a Dispute 
Settlement Process through the WTO. The negotiation deadlocked, and after 60 days, 
a panel was appointed to adjudicate on the issue of the E.U.’s de facto ban on GM 
foods. Wong, supra note 7, ¶1.   
133 Europe Reflects Italian Battle, supra note 132.  
134 GMO Update: WTO Biotech Case, ISAAA, EU, APEC, 6 BRIDGES TRADE 
BIORES 1, Jan. 20, 2006, available at http://www.ictsd.org/biores/06-01-
20/story3.htm. 
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not be issued until February 2006.135 One commentator compared 
the WTO with the game of poker, where “every player must be 
aware of the rules and work within their confines in order to 
succeed.”136 He added that “[w]hile each player is familiar with the 
house rules, whether the WTO is equipped to handle genetic 
engineering concerns remains to be seen.”137  
While the decision is pending, certain predictions can be made 
based on precedents. In 1997, the WTO supported the U.S. position 
in the dispute that arose between the United States and the E.U. 
over the European ban on the importation of beef containing 
synthetic growth hormone that farmers had administered to cows to 
enhance their growth.138 The WTO ruled that the European ban was 
not based “on scientific evidence, risk assessment, or relevant 
international standards….”139 Still, the issue of the E.U.’s ban on 
GMOs is not a clear-cut case for the United States because the 
WTO will have to decide whether the E.U.’s GMO restrictions fit 
into a GATT Article XX exception for the protection of “human, 
animal, or plant life or health.”140 Even though the precautionary 
principle adopted by the E.U. had little support in WTO precedents, 
it can potentially be considered as customary international law, and 
 
 
135 Id.  
136 Borg, supra note 28, at 696–97. 
137 Id. at 697.  
138 Wilson Huhn, Three Legal Frameworks for Regulating Genetic Technology, 
19 J. CONTEMP. HEALTH L. & POL’Y 1, 34–35 (2002). Certain socio-political factors 
may account for the differences between the U.S. and E.U. positions: 
 
The United States, an individualistic society with a capitalistic 
economy, is likely to continue to approach [the] issues [of 
biotechnology] from a rights or a scientific regulation perspective, 
while more communitarian societies that have a stronger 
commitment to traditional values will opt for a stricter regulatory 
regime or for legislative preemption. National preferences for 
different models of regulation will hamper the development of a 
rational and comprehensive scheme of international regulation of 
biotechnology. 
 
Id. at 35.   
139 Id. at 34. The WTO ordered the E.U. to pay the United States over US$100 
million in damages that incurred as a result of the ban on the importation of hormone-
treated beef. Id. at 35.     
140 Bridges, supra note 117, at 183 (quoting TBT Agreement, supra note 99, at 
preamble).   
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as such, the WTO cannot ignore it.141 Accordingly, there is a sound 
possibility that the WTO will uphold E.U. restrictions on the 
importation of GMOs.  
 
III. POLITICAL AND SOCIAL CONTEXT OF GMO REGULATIONS 
 AND CONFLICTING PRIORITIES BETWEEN  
THE UNITED STATES AND THE EUROPEAN UNION 
 
Biotechnology is young and developing at a rapid pace, making 
it hard for consumers and governments worldwide to adjust.142 
Consumer groups are putting pressure on the FDA “to require 
mandatory, transparent reviews and appropriate labeling….”143 The 
movement seems to echo the European trend of opposing 
biotechnology.144  
At the root of this disagreement are a number of clashing legal 
principles and cultural values between the United States and the 
E.U. member-states. The United States has been at the forefront of 
biotechnological developments and one of the first countries to 
apply them to agricultural industry, harvesting GM crops on 
millions of acres of land.145 Accordingly, liberal regulations of GM 
foods in the United States derive from the profound interest of the 
government and businesses in international exports of these 
advanced crops.146 Furthermore, lobbyists for the GE industry 
greatly influence agricultural departments who receive financial 
incentives to promote the GE industry.147   
The members of the E.U., however, do not share this attitude. 
They follow a more cautious approach and implement significant 
restrictions on imports of GM foods as well as rigid labeling 
standards.148 Due to safety concerns, the E.U. member states and 
 
 
141 Id. at 184 (arguing that because the precautionary principle is used worldwide 
in cases of scientific uncertainty, “the WTO should accept the EU’s restrictions as 
necessary and reasonable” because the E.U. used the precautionary principle to design 
their GMO regulations). 
142 Compton, supra note 10, at 364–65. 
143 Suh, supra note 1.  
144 Id. Labeling has been or is likely to be adopted by about forty-eight countries. 
See Harl, supra note 31, at 4. 
145 Compton, supra note 10, at 365. 
146 Id.  
147 Shah, supra note 130.  
148 Compton, supra note 10, at 365.  
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many other WTO members enacted trade restrictions on the 
importation of GM foods.149  
There is a difficult controversy over the need to provide 
safeguards due to the lack of knowledge regarding the long-term 
effects of biotechnology.150 Scientific studies have exposed certain 
risks to humans, such as allergic reactions, and more potential 
harms may exist.151 Risks to the environment also remain uncertain. 
Although many speculations take place in the scientific community, 
some predict unintended, permanent damage to our ecosystem.152 
Supporters, however, say that the known benefits of biotechnology 
outweigh the potential risks.153 They also stress the need to use 
biotechnology to help developing countries fight hunger and 
malnutrition.154  
A range of cultural values also need to be taken into 
consideration. Even if GM foods were safe in every aspect and 
safety was not an issue, disagreements regarding the use of 
biotechnology would probably not cease.155 Many attitudes toward 
biotechnology are based on cultural values and ethical concerns, 
and certain countries may have “a real, but unquantifiable, 
unverifiable, non-science-based aversion to a certain product.”156  
When the United States embraced biotechnology, many foreign 
consumers vehemently voiced their opposition based not only on 
safety, but also on their uneasiness with the idea that U.S. 
corporations would “dare to ‘play God’ by altering the genetic 
make-up of plants.”157 Many people are uncomfortable with change. 
 
 
149 McDonald, supra note 39, at 503–04. 
150 Id. at 504.  
151 Id.  
152 Id. 
153 See id. at 520. 
154 Id. at 521.  
155 Frank Loy, Genetically Modified Organisms: Colloquium Article Statement 
on Biotechnology: A Discussion of Four Important Issues in the Biotechnology 
Debate, 8 N.Y.U. ENVTL. L.J. 605, 605 (2000). 
156 Id.  
157 Brooks, supra note 31, at 154. Europeans express ethical concerns regarding 
biotechnology because they feel that “genetic modification or engineering of crops is 
not a natural extension of traditional plant breeding techniques as it violates a ‘natural 
order’ which should be respected and not violated.” Wong, supra note 7, ¶ 6. 
Proponents of biotechnology, however, say that genetic modification is just a modern 
form of selective breeding, in which people have engaged for centuries and which has 
proven to be safe. Rich, supra note 28, at 890. See Thomas O. McGarity, Seeds of 
Distrust: Federal Regulation of Genetically Modified Foods, 35 U. MICH. J.L. 
REFORM. 403, 427 (2002) (arguing that unlike traditional breeding that “take[s] 
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Because scientific evolution has been so rapid, people’s mentalities 
have not had enough time to adjust. The United States greatly relies 
on technology, which may help explain why people in the United 
States are more comfortable with biotechnology than people in 
other countries who do not have the same trust for or reliance on 
technology.158  
A number of other theories exist that help explain the reasons 
for public opposition to biotechnology in Europe. In recent years, 
for example, Europe has suffered a number of health scares, such as 
the “mad cow disease” and dioxin-tainted products.159 Epidemics of 
this kind naturally make consumers anxious about the foods placed 
on the market, especially when those foods are novel and 
controversial. Alternately, European apprehension over GM foods 
may stem from the “more enduring ties between urban populations 
and agriculture and food products.”160 Europeans conceptualize 
food in a way that attaches symbolic value to it. “In many European 
countries there is a strong link between culture and food…David 
Byrne, the EU Health and Consumer Safety Commissioner, has 
said, referring to food quality, that ‘[f]or some member states it’s 
nearly synonymous with sovereignty.’”161 As a result, “the degree 
of risk of GM food products may not be as important…as the fact 
that this risk touches something of great symbolic importance,” 
rather than just “a means of survival.”162 Still some hold that the 
                                                                                                          
advantage of nature’s vast storehouse of information”, biotechnology accomplishes 
changes “that could never occur in nature”). Consequently, “[b]ecause modern genetic 
engineering is a hit-or-miss process that ‘disrupts the existing genome in a random 
way,’ it is more likely to create unexpected, unintended side effects than the 
conventional approaches.” Id. at 427–28. Furthermore, “[t]he new technology allows 
for a far greater number of organisms to be produced at a far greater speed compared 
to traditional methods, and the collective impact of these organisms presents problems 
for risk assessment.” Rich, supra note 28, at 891. Contra J. Howard Beales III, 
Modification and Consumer Information: Modern Biotechnology and the Regulation 
of Information, 55 FOOD & DRUG L.J. 105, 105–06 (2000) (arguing that genetic 
engineering is “not fundamentally different from old methods of selective breeding”).   
158 Brooks, supra note 31, at 162. 
159 Emily Marden, Risk and Regulation: U.S. Regulatory Policy on Genetically 
Modified Food and Agriculture, 44 B.C. L. REV. 733, 744 (2003).   
160 Id.  
161 Brian P. Rafferty, The Door Opens Slightly: Recent European Union 
Regulations on Genetically Modified Products and the Ongoing United States-
European Union GM Product Dispute, 16 GEO. INT’L ENVTL. L. REV. 281, 295 (2004) 
(quoting Lizette Alvarez, Consumers in Europe Resist Gene-Altered Foods, N.Y. 
TIMES, Feb. 11, 2003, at A3) (discussing the roots of the European views on GM 
food). 
162 Id. at 295. 
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European objection to biotechnology is “simply an indirect route 
for rejecting American corporate arrogance.”163 In all likelihood, 
however, no single factor is responsible for the European reaction 
to genetic engineering and many different variables contribute to 
that attitude.164  
In August 2003, the OECD held a biotechnology conference in 
Europe.165 The conference report listed the issues of general 
agreement as well as the more controversial issues that did not 
reach agreement.166 The parties did, however, reach a consensus 
regarding the need for more public discussion as well as research.167 
The areas of disagreement included moral issues, environmental 
concerns, and mandatory labeling of GM foods.168 Authors of a 
paper written for the biotechnology conference stressed the need 
for a long-term strategy and proposed a “holistic approach” that 
would benefit the industry, the science, and the consumers.169 They 
remained optimistic that the European public would warm up to 
biotechnology, as long as effort was put into rebuilding consumer 
confidence, which is what the industry is trying to do by 
introducing new products that will benefit the public.170  
 
IV. THE NEED FOR MORE PUBLIC DISCUSSION IN THE DECISION-
MAKING PROCESS AND THE IMPORTANCE OF INFORMED  
CONSUMER CHOICE 
 
Studies on consumer perception show that support for GM 
foods has declined due to the weakening of consumer trust in 
governmental regulation.171 No matter how much money gets 
pumped into the GE industry, “developers and producers’ money 
and efforts are wasted if consumers lack confidence in the 
 
 
163 Marden, supra note 159, at 744–45. 
164 Id. at 745.  
165 Compton, supra note 10, at 370. 
166 Id. at 370–71. 
167 Id. at 370.  
168 Id. at 370–71. 
169 John Mason, European Consumers Put Up Tough Fight: Genetically 
Modified Food: The Debate About GM Food Is More Heated in the UK and the Rest 
of Europe Than It Is Elsewhere, FIN. TIMES (London), Sept. 8, 2004, at 4. 
170 Id.  
171 See Compton, supra note 10, at 365 (2003) (interpreting the studies by 
Thomas Hoban, professor of sociology and food science at North Carolina State 
University in Raleigh). 
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product.”172 Accordingly, the “consumer right-to-know” is at the 
core of the GM controversy.173  
 
A. Informed Consumer Choice Issues in the United States 
 
The Federal Food, Drug and Cosmetic Act of 1938 (“FDCA”) 
prohibits misbranding and misleading representations about food 
and requires that certain essential information be included on a 
label.174 Specifically, five pieces of information are required: (1) 
“the name and place of business of the manufacturer, packer, or 
distributor;” (2) “an accurate statement of the quantity of the 
contents in terms of weight, measure, or numerical count;” (3) “the 
common or usual name of the food;” (4) “the common or usual 
name of each…ingredient” (if two or more ingredients are used); 
and (5) a label containing complete nutritional information.175 The 
purpose of the label is to provide consumers with essential 
information about the food, but due to the limited space on a label, 
the FDA only requires the inclusion of crucial information.176 The 
FDA does not consider information on genetic modification crucial, 
thereby influencing its view that the FDCA does not require the 
labeling of foods derived from biotechnology.177 Moreover, in spite 
of consumer demands for more information regarding genetic 
engineering, the FDA argues that including such information would 
only clutter food labels with unnecessarily confusing messages and 
thus decrease the effectiveness and utility of labeling.178 For this 
reason, the agency is even wary of voluntary labeling of GM foods 
because it can potentially mislead consumers who, due to lack of 
information, may assume that genetic engineering results in unsafe 
foods, thereby deterring people from purchasing foods that may, in 
fact, have higher nutritional value than conventional foods.179 
Accordingly, the FDCA condemns statements they consider 
 
 
172 Christine Cochran, Premarket Notice Concerning Bioengineered Foods: A 
Proposed Regulation Satisfying Some of the Players, Some of the Time, 12 WASH. U. 
J.L. & POL’Y 173, 200 (2003) (suggesting that the government, producers, and 
developers of GMOs should put efforts into educating the public about biotechnology 
before fear of the unknown causes the public to completely reject it).   
173 Degnan, supra note 88, at 50. 
174 21 U.S.C. § 343 (2004). 
175 21 U.S.C. § 343(e),(i),(q) (2004). 
176 Degnan, supra note 88, at 55. 
177 Id. 
178 Id. at 55–56. 
179 See id. at 49.  
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misleading, even when ambiguity results from “the use of 
statements not technically false or which may be literally true.”180 
Perhaps, a seemingly better solution would be to educate the public 
rather than to carefully craft the food labels in a way that shields 
consumers from the information that would allow them to make 
wise, educated decisions and shop with confidence.  
The industry’s resistance to labeling is not the only hurdle 
consumers have to overcome before succeeding in convincing 
Congress to give the FDA authority to mandate labeling; there are 
also important constitutional issues at hand. Even if the FDA had 
authority to mandate labeling, the Supreme Court may hold such 
requirement unconstitutional with regard to commercial speech.181 
Commercial speech is protected by the First Amendment, and such 
speech may only be compelled if a substantial governmental 
interest is present.182 Mere consumer desire for more information to 
satisfy curiosity does not rise to the level of a compelling 
governmental interest under constitutional scrutiny.183 However, it 
is not mere curiosity, but health concerns and potential 
environmental risks that guide many consumers to pursue 
mandatory labeling.184 Even these concerns, however, are not likely 
to be enough to meet the required threshold of scrutiny because of 
the present consensus between the FDA and the National Academy 
of Sciences, which concludes that foods derived by means of 
biotechnology do not differ substantially from traditional 
products.185  
A case that illustrates this constitutional issue is International 
Dairy Foods Ass’n[BB 10.2.1(c)] v. Amestoy, 92 F.3d 67 (1996), 
where dairy manufacturers challenged the constitutionality of a 
Vermont statute requiring identification of milk products that came 
from cows that were given bovine growth hormone (“rBST”) to 
increase milk production.186 The Second Circuit Court of Appeals 
 
 
180 United States v. Ninety-Five Barrels (More or Less) Alleged Apple Cider 
Vinegar, 265 U.S. 438, 443 (1924). In this case, a manufacturer was charged with 
misbranding of vinegar produced from dried apples as “apple cider vinegar.” Id. at 
439. The U.S. Supreme Court found that the label was misleading and therefore the 
vinegar was misbranded. Id.    
181 Jonathan Adler, Regulating Genetically Modified Foods: Is Mandatory 
Labeling the Right Answer?, 10 RICH. J.L. & TECH. 14, ¶ 1 (2004).   
182 Id. ¶ 6.   
183 Id. ¶ 8.  
184 Id.  
185 Id.  
186 Int’l Dairy Foods Ass’n v. Amestoy, 92 F.3d 67, 69–70 (2d Cir. 1996). 
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held that since rBST-derived milk was undistinguishable from 
regular milk, and since Vermont could not prove the existence of 
harm, the State of Vermont could not compel the dairy 
manufacturers to “speak against their will.”187 The court further 
stated that “consumer curiosity alone is not a strong enough state 
interest to sustain the compulsion of even an accurate, factual 
statement.”188 “[T]he government must have…a substantial 
governmental interest to infringe upon commercial speech,” such as 
“unidentifiable health risks, an economic impact, or a physical 
impact on the consumer.”189 This is a difficult burden to overcome 
to justify labeling when all the regulatory agencies are in consensus 
about the safety of GM foods.190 However, if proponents narrowly 
tailored labeling requirements, such as applying it to potentially 
allergenic products, the requirements may pass the threshold of 
constitutionality.191  
There may be other considerations about mandatory labeling 
that would give grounds to a constitutional barrier: 
 
[T]he GM debate…is mostly about values and about 
ethical concerns. This fact raises an additional red 
flag under the First Amendment because the Court 
has always been very sensitive to the idea that 
compelling an individual to give voice to a 
controversial message, or to make a statement with 
which they disagree, is something that the 
government should rarely be allowed to do…. 
 
A GMO labeling requirement would be likely to 
face additional scrutiny because there would be real 
suspicion that the basis for the labeling is not health 
concerns, but political control over the sorts of 
messages and values that we communicate in the 
food distribution process and in the food market 
process. In that context, courts have made it clear 
that those are the sorts of debates that the 
 
 
187 Id. at 74. 
188 Id.  
189 Adler, supra note 181, ¶ 7. 
190 Id. ¶ 8. 
191 See id. ¶ 11.  
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government should stay out of and should be left to 
the market place of ideas.192 
 
Admittedly, even though biotechnology carries potential risks, 
the constitutional protection on commercial free speech makes it 
very difficult to impose mandatory labeling in the United States, 
absent any explicit evidence of real harm. Despite the possible 
constitutional barrier, if the public applies enough pressure, there 
are “other non-governmental labeling schemes which can rise up 
and provide consumers with the sort of information that they may, 
for very good reasons, feel that they want or need when they are 
deciding what products to buy.”193 
Eventually, changes will likely take place because of growing 
consumer demands for information, irrespective of the safety issue. 
Seventy-five percent of the respondents of the Pew poll in 2001 
pointed to the importance of being aware of the presence of GM 
ingredients in their food.194 In 2003, eighty-nine percent of poll 
respondents expressed the need for mandatory FDA review before 
the marketing of GM products.195 In 2002, a bill was introduced in 
 
 
192 Id. ¶¶ 13–14. 
193 Id. ¶ 16. 
194 Suh, supra note 41. See Cynthia D. Fisher, The Genie Is Out of the Bottle: 
Consumers Demand Mandatory Labeling on Genetically Engineered Foods, 4 J. 
LEGAL ADVOC. & PRAC. 88 (2002). Other polls report similar findings:  
 
In June 2001, an ABC News telephone poll revealed that ninety-
three percent of American people support labeling genetically 
engineered (“GE”) foods, and fifty-two percent believe GE foods 
are unsafe. Time Magazine similarly reported that eighty-one 
percent of Americans polled support mandatory labeling of GE 
foods. The Center for Food Safety, a Washington D.C. scientific 
thinktank and grassroots forum for litigation support and 
dissemination of issues surrounding food safety, provides a 
comprehensive report of polls taken throughout the United States. 
This investigation revealed an overwhelming demand for 
mandatory labels on GE foods. Such studies show that while 
consumers are generally not opposed to GE foods, they are 
adamantly against allowing such foods to be sold without adequate 
labeling.  
 
Id.  
195 Suh, supra note 41 (discussing a recent Pew poll where respondents were 
asked to evaluate the statement: “[c]ompanies should be required to submit safety data 
to the FDA for review, and no genetically modified food product should be allowed on 
the market until the FDA determines it is safe”). 
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the Senate “that would require FDA approval for all GE food with 
safety data made public and open to comment.”196 The bill was 
referred to the Senate committee on October 10, 2002, and then to 
the Committee on Agriculture, Nutrition, and Forestry.197 No 
subsequent major action has been taken with regard to the bill.198  
The continual disregard for consumer concerns will eventually 
backfire. Two California counties have recently banned GM crops 
because of the agricultural industry’s failure to address the public’s 
fears.199 Because of the undisputed benefits of GM foods, banning 
such crops is not a good strategy. However, it was a natural 
reaction to the “information vacuum” created by the industry’s 
refusal to educate the public and address consumer fears.200 The 
industry refuses to budge on the labeling issue, but “[i]f biotech and 
agriculture companies want people to make sensible choices, they’ll 
have to trust them with more information.”201 
The U.S. position has been to deny people their right to know 
how something is produced and to instead align with biotech 
companies that cumulatively spend approximately fifty million 
dollars per year propagating biotech foods.202 The ways in which 
the U.S. agencies handle GM food regulation send a message that 
citizen demands should be ignored.203 Many European countries 
also feel that the United States puts too much pressure on and 
interferes with the decision-making process in other countries.204 
The U.S. regulators, on the other hand, are frustrated with the 
 
 
196 Id. (discussing the bill introduced by Sen. Richard Durbin, D-Ill.). 
197 A Bill to Amend the Federal Food, Drug, and Cosmetic Act to 
Require Premarket Consultation and Approval with Respect to Genetically 
Engineered Foods, and for Other Purposes, http://thomas.loc.gov/cgi-
bin/bdquery/z?d107:SN03095:@@@L&summ2=m&#status (last visited Feb. 6, 2006) 
(providing detailed information about the bill, including its summary and current 
status). 
198 Id.  
199 Paul Holmes, CA Movement to Ban Modified Crop Stems from Industry’s 
Refusal to Inform the Public, PRWEEK (U.S.), Aug. 30, 2004, at 9. 
200 Id.  
201 Id.  
202 Shah, supra note 130; Fisher, supra note 194, at 89 (discussing how newly 
developed biotech foods rapidly moved into the marketplace in the United States and 
abroad due to the efforts of a small number of United States biotech companies, 
marketing GE foods as a solution to world hunger and environmental problems).   
203 Shah, supra note 130. See Rich, supra note 28, at 906 (arguing that it is 
irresponsible of the Government to ignore consumers’ concerns and that such 
approach “denotes a paternalistic approach to public policy”).  
204 Shah, supra note 130.   
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Europeans’ resistance to GM foods and claim that their objections 
are unreasonable and purely emotional.205 
 
B. Informed Consumer Choice Issues on the International Scene 
 
The regulatory philosophy of the E.U. includes much more of 
the conflicting viewpoints of consumers, scientists, and 
manufacturers, and reflects a more democratic approach to 
labeling.206 Although different legislative institutions have a range 
of dissimilar theories on what criteria they should use for labeling, 
there is a consensus among lawmakers that it is necessary to label 
biotechnology products.207  
Of particular curiosity is that while the U.S. regulatory agencies 
oppose labeling of GM foods because it can be misleading and 
confusing to consumers,208 the E.U. requires labeling in order to 
prevent consumers from being misled.209 The Economic and Social 
Research Council (ESRC) strongly believes that “[t]o assume that 
the public is ignorant is not only patronizing, but inaccurate and 
damaging. Global Environmental Change Programme research 
reveals that people’s understandings of the issues are very much 
better developed than these characterizations imply.”210  
 
V. CONCLUSION 
 
Many scientists agree that although GM food is basically safe, 
there could be potential long-term effects. Consequently, there is a 
need for independent, objective, unbiased research to explore 
possible undesirable effects of biotechnology. The rapid advances 
in biotechnology and the increased presence of GM foods in 
markets and grocery stores worldwide further aggravate the need 
for such research.  
 
 
205 Kathleen Hart, a journalist writing about health and biotechnology, called the 
USDA in order to clarify why the Europeans are so apprehensive about biotechnology. 
An assistant to then Agriculture Secretary Dan Glickman assured Ms. Hart that GM 
foods do not differ nutritionally from conventional foods and that “[t]he Europeans 
were basing their objections not on science…but on emotion.” Hart, supra note 5, ¶ 6. 
206 Degnan, supra note 88, at 56.   
207 Id. at 57.  
208 Id. at 49. 
209 Compton, supra note 10, at 383. 
210 ESRC GLOBAL ENVTL. CHANGE PROGRAMME, THE POLITICS OF GM FOOD: 
RISK, SCIENCE AND PUBLIC TRUST, special briefing No. 5 (1999), http://www.sussex. 
ac.uk/Units/gec/gecko/gec-gm-f.pdf. 
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Like any scientific development, biotechnology can be used for 
various purposes. It can be “democratically managed to the benefit 
of the most needy or skewed to the advantage of specific groups 
that hold the vital political, economical and technological 
power.”211 After analyzing the progress of bioengineering nearly 
two decades ago, Senator Al Gore warned that “[f]or every use of 
biotechnology there is potential misuse. For every benefit, there is a 
potential hazard. Our challenge is to know when we are about to go 
too far.”212 Therefore, in order to maximize the possibilities and 
prevent the hazards, governments and people must use this power 
rationally.213 
The current U.S. system is fragmented and insufficient to 
protect consumers because it excludes the public from the decision-
making process. One commentator criticized the current system’s 
inability to effectively address the environmental impact of 
biotechnology: 
 
At present, the environmental risks posed by 
genetically engineered organisms are not addressed 
in a coherent manner. There is no single federal 
statute that governs the subject matter. The 
regulatory regime that does exist only confronts a 
few aspects of the issue, and then only in a 
piecemeal, haphazard fashion…. Consequently, 
there are sizable gaps in coverage, with the 
concomitant risk of significant harms slipping 
through the cracks and into the environment. 
Additionally, proponents of new and potentially 
important genetically engineered “products” are 
forced to navigate a confusing maze of agencies and 
statutes, with resulting inefficiency and needlessly 
steep economic and opportunity costs and delays for 
industry and the general public.214 
 
 
211 MacLaughlin, supra note 46, at 405. 
212 Albert Gore Jr., Federal Biotechnology Policy: The Perils of Progress and 
the Risks of Uncertainty, 20 U. MICH. J.L. REFORM  965, 967 (1987). 
213 See id.  
214 John Charles Kunich, Mother Frankenstein, Doctor Nature, and the 
Environmental Law of Genetic Engineering, 74 S.C. L. REV. 807, 823 (2001). Due to 
the ineffectiveness of the current interdependent system, a new agency should be 
created in place of the existing regulatory framework. The EPA would be the sole 
agency regulating GMOs under the authority of the Transgenic Release Act (“TRA”) 
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The United States needs a more centralized regulatory system. 
Since increasing and ensuring cooperation between the USDA, 
EPA, and FDA will be very difficult, a better approach would be to 
create a separate federal agency responsible solely for the research 
and regulation of genetically modified organisms. Instead of 
relying on the existing regulatory framework, new laws should be 
created that would correspond with the demands of biotechnology. 
The creation of a new regime will help improve existing protections 
for the health of the consumers and the health of the planet.  
Furthermore, the United States should adopt labeling standards 
to allow consumers to make an informed decision as well as to 
instruct, warn, and educate them about choosing their food wisely. 
Consumers should have a forum to address their concerns and those 
concerns should be listened to—“[t]his is the essence of a 
representative government, a fact not lost to the biotech industry, 
which has taken full advantage of their lobbying power to ensure 
technology-friendly regulations.”215  
As for the European policy, as it becomes more liberal in the 
interest of improving trade relationships, it needs to remain aware 
of other important considerations. The recent changes towards trade 
liberalization in Europe are positive for both the E.U. and the 
United States. Banning biotechnology, which has so much 
potential, is not a good policy, and Europe should be praised for 
finally giving genetic engineering a chance to prove its utility. 
However, the focus should remain on rational management. 
Eventually, the governments and people will be able to achieve a 
happy medium because while the United States is tightening its 
                                                                                                          
proposed herein. The statute shall “make sense on a scientific level,” taking into 
consideration both the risks and benefits of biotechnology. Moreover, the statute, 
“should be an effective mechanism for educating the general public and creating a 
productive dialogue with people in the communities most directly affected.” Id. at 
863–70.   
215 Rich, supra note 28, at 906. See Emily Robertson, Note, Finding a 
Compromise in the Debate over Genetically Modified Food: An Introduction to a 
Model State Consumer Right-to-Know Act, 9 B.U. J. SCI. & TECH. L. 156, 158 (2003) 
(advocating mandatory disclosure of GMOs in food products because consumers 
should be able to make informed decisions and “meaningfully participate in [the] 
marketplace”); see also Rebecca M. Bratspies, Consuming (F)ears of Corn: Public 
Health and Biopharming, 30 AM. J.L. & MED. 371, 403 (2004) (stating that decisions 
regarding the regulation of GM foods “should be the product of a public discussion 
and decision-making process, not the byproduct of private economic ordering”); 
Rebecca Bratspies, The Illusion of Care: Regulation, Uncertainty, and Genetically 
Modified Food Crops, 10 N.Y.U. ENVTL. L.J. 297, 355 (2002) (stating that because of 
the corrosive effects of public distrust of the regulatory system, precautionary controls 
need to be developed that would “enjoy the confidence of the public”).   
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laws regarding biotechnology, European policy is becoming more 
non-interventional.   
The opportunities are great as long as the agenda includes 
filling the informational void that has been growing since the 
introduction of biotechnology to consumers, catching them in the 
crossfire between competing claims and interests.  
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